Related Experiment Video
Updated: Mar 23, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
[Mild cognitive impairment]
Abstract:
Mild cognitive impairment(MCI) is considered to be a transition state between normal cognition and dementia. The subtypes of MCI are highly heterogeneous in terms of etiology, presentation, and prognosis. Patients with the amnestic subtype of MCI are at a high risk of progression to Alzheimer disease (AD); this subtype may represent the prodromal stage of AD. Moreover, patients with MCI who are not aware of their memory deficits and in whom practice effects are not observed exhibit parietotemporal hypoperfusion on single photon emission CT, indicating that these findings are predictors of progression to AD. In this review, I have discussed the most current aspects related to the concept and clinical presentation of MCI.
Insights
Mild cognitive impairment (MCI) is a transitional stage to dementia. Certain MCI subtypes, particularly amnestic MCI, indicate a high risk for Alzheimer's disease progression, showing specific brain perfusion patterns.
Area of Science:
- Neurology
- Neuroscience
- Geriatrics
Background:
- Mild cognitive impairment (MCI) represents a critical transitional phase between normal cognition and dementia.
- MCI subtypes exhibit significant heterogeneity in causes, clinical manifestations, and outcomes.
- The amnestic subtype of MCI is strongly associated with an elevated risk of progressing to Alzheimer's disease (AD), potentially signifying its prodromal stage.
Purpose of the Study:
- To review the current understanding of Mild Cognitive Impairment (MCI).
- To discuss the clinical presentation and diagnostic indicators of MCI.
- To highlight the association between specific MCI subtypes and Alzheimer's disease progression.
Main Methods:
- Literature review of current research on Mild Cognitive Impairment (MCI).
- Analysis of studies examining the relationship between MCI subtypes and Alzheimer's disease (AD).
- Discussion of neuroimaging findings, such as single-photon emission computed tomography (SPECT) in MCI patients.
Main Results:
- Patients with amnestic MCI face a heightened risk of developing Alzheimer's disease (AD).
- Parietotemporal hypoperfusion on SPECT scans in unaware MCI patients without practice effects predicts AD progression.
- MCI is a heterogeneous condition with varying etiologies and prognoses.
Conclusions:
- MCI is a significant precursor to dementia, especially Alzheimer's disease.
- Identifying specific MCI subtypes and neuroimaging markers can aid in predicting AD progression.
- Understanding MCI's concept and clinical presentation is crucial for early diagnosis and intervention.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
Related Concept Videos
Cognitive Development During Adulthood
Intellectual Disability
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Language and Cognition